Member Info for Dougie999

http://www.dailymail.co.uk/health/article-5133139/Price-spray-help-men-10-times-longer-slashed.html

https://www.thesun.co.uk/fabulous/5037148/100-*****-spray-men-last-longer-slashed-20-christmas/ http://www.dailymail.co.uk/health/article-5133139/Price-spray-help-men-10-times-longer-slashed.html https://www.doctor-4-u.co.uk/fortacin.html

yeh it seems majorly unrealistic and exaggerated the figures that were previously branded around by RP announcements. Talk of billions etc... It will be interesting to see if we get any sort of feedback in the near future of UK sales performance, I know it started small but if repeat purchases were happening it would be a good indicator. When are we due any sort of announcement regarding US developments or Recordati plans? It will need some big exposure in EU from Recordati to get the sales going in my humble opinion

from reading over the last few posts Pom I assume you are talking of JM investment when saying 30m to 300m. He's got a 30 % stake so thats valuing the company at 900m? way over the top dont you think or maybe i have read it wrong and you simply mean the company at 300 m

if the company sold plethora, what would happen for shareholders? obviously RPG would stilll exist so would we just see a share price rise or we would receive a certain price per share? or have the option?

As i recall, that JM tweet you refer to was in response to someone asking him about the worth of RPG and how the share price was sliding, I don't remember it being about a RTO? What could be simmering in the background in your mind Pom? I thought we are in a quiet period now before EU launch, not heard anything for a long time about licensing deals for China etc and I suppose maybe something about USA could have developed but never know when news will pop up

great insight ! you appeared to miss my final thought though.. . I assume the proprietary technology could be attractive to a pharma who may be interested in Fortacin as it could be used with an existing product they have??

appreciate the detail you go into Pom. I assume the proprietary technology could be attractive to a pharma who may be interested in Fortacin as it could be used with an existing product they have?? also you also state the PRO 008 is due early 2018?? is that not a year early ? apologies if I have misinterpreted your post

I recall not long ago someone on here talking about how fortacins spray mechanism could be potentially used with viagra like products for patients who pills dont work on... Can anyone explain what is so unique about fortacins spray mechanism that makes it an asset? seems pretty simple to me but i remember as well reading how it offered a big opportunity

I see the price of fortacin has been raised on the chemist 4 u website.... https://www.chemist-4-u.com/catalogsearch/result/?dir=desc&q=fortacin

can someone please explain the situation with this tax case? also, why do Regent have a large investment in Venturex?

are you all hoping end game is to sell off to a big player? with the mix of negativity and positivity on the board its hard to understand why some people are invested

have you seen sales figures for promanescent ? the comparison of the 2 shows fortacin to be of much greater benefit to people. what row licenses could we be waiting for ?

what would you guys forecast share price could reach come march when the initial payments are received and product launched? obviously the uk launch gave a big spike but surely this will be of much greater significance? ....unless as has been rumoured a stake builder is finished loading up and happy with their lot

http://www.regentpac.com/ICMServlet/download/13-2158-3515/EAnnt-EUImplementingDecision(02Nov2017).pdf

what kind of broker do you have who told you the year for rpg was going to be massive?

New drug in pipeline? And what�s your thoughts on Macau reason?

4 years? half that I think maximum

does anyone have an idea of a commitment from recordati to spend a certain amount on marketing for europe? also, how the product is likely to be marketed in USA to reach the target market?

also interested to hear the thoughts of posters regarding the home straight i believe we are now on to achieve the promised land of fda approval. do you believe we will hold and rise share price as we progress with europe sales and fda trialling? positive times ahead